Showing results (1-10 of 170) with videos related to
Sort By:
Pageof 17
Leukemia & Lymphoma|March 21, 2017
Novel agents in classical Hodgkin lymphomaSven Borchmann, Bastian von TresckowCurrent Opinion in Oncology|July 26, 2016
Current developments in the treatment of early-stage classical Hodgkin lymphomaSven Borchmann, Bastian von Tresckow, Andreas EngertCurrent Opinion in Oncology|August 15, 2013
Refractory Hodgkin lymphomaBastian von Tresckow, Andreas EngertCurrent Hematologic Malignancy Reports|May 14, 2011
The role of autologous transplantation in Hodgkin lymphomaBastian von Tresckow, Andreas EngertExpert Review of Hematology|November 14, 2012
The emerging role of PET in Hodgkin lymphoma patients receiving autologous stem cell transplantBastian von Tresckow, Andreas EngertHaematologica|May 28, 2026
On closing the gap: anti-PD-1-based salvage in relapsed/refractory classical Hodgkin lymphoma. Comment on: "Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma"Hishan Tharmaseelan, Bastian Von TresckowExpert Opinion on Emerging Drugs|April 23, 2014
An update on emerging drugs for Hodgkin lymphomaBastian von Tresckow, Volker DiehlSeminars in Hematology|August 7, 2016
Treatment of relapsed and refractory Hodgkin LymphomaBastian von Tresckow, Craig H MoskowitzDeutsche Medizinische Wochenschrift (1946)|May 15, 2024
[T-cell recruiting immunotherapies in B-cell lymphoma - the future backbone for all therapy lines?]Veit Bücklein, Bastian von Tresckow, Marion SubkleweJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2019
Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin LymphomaSven Borchmann, Melita Cirillo, Helen Goergen, et al.Pageof 17